Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”

Yuanbin Liu ,  Mingkai Chen

Clinical and Molecular Hepatology

2023 .01

Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways

Seung Min Lee ,  Dong Hee Koh ,  Dae Won Jun 외 4명

Clinical and Molecular Hepatology

2022 .10

Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait

Ca ,  los J. Pi ,  ola 외 1명

Clinical and Molecular Hepatology

2022 .10

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?

Ma ,  ga ,  et LP Teng 외 4명

Clinical and Molecular Hepatology

2023 .04

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future

Asako Nogami ,  Masato Yoneda ,  Michihi 외 8명

Clinical and Molecular Hepatology

2023 .02

Effect of Korean Red Ginseng in chronic liver disease

Tae Young Pa ,  k ,  Meegun Hong 외 3명

Journal of Ginseng Research

2017 .10

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease

한유진

Diabetes and Metabolism Journal

2022 .07

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?

Ju Hyun Shim

Clinical and Molecular Hepatology

2020 .01

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments

Sang Bong Ahn

Clinical and Molecular Hepatology

2023 .02

The growing burden of non-alcoholic fatty liver disease on mortality

Ju-Yeon Cho ,  Won Sohn

Clinical and Molecular Hepatology

2023 .04

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease

정한나 ,  정창희

Diabetes and Metabolism Journal

2023 .03

Reply to Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”

Ka Shing Cheung ,  Chiu Hang Mok ,  Wai Kay Seto 외 1명

Clinical and Molecular Hepatology

2023 .01

Implications of comorbidities in nonalcoholic fatty liver disease

She ,  lot Juan Song ,  Vincent Wai-Sun Wong

Clinical and Molecular Hepatology

2023 .04

Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology

Eileen Lau ,  el Yoon ,  Dae Won Jun

Clinical and Molecular Hepatology

2023 .04

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease

Maamon Bashee ,  Mohamed Naffaa ,  Nime 외 1명

Clinical and Molecular Hepatology

2023 .04

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease

Byeong Geun Song ,  Dong Hyun Sinn

Clinical and Molecular Hepatology

2023 .04

Performance comparisons of two biomarker-based panels for early diagnosis of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multi-institutional case-control analysis

Wei OUYANG ,  Ming-Cheng GUAN ,  Si-Yu LIU 외 7명

Annals of Hepato-Biliary-Pancreatic Surgery

2022 .12

Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease

정우경

Gut and Liver

2017 .01

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Seong Hee Kang ,  Hye Won Lee ,  Jeong-Ju Yoo 외 18명

Clinical and Molecular Hepatology

2021 .01

Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

서다혜 ,  서영주 ,  Cho Yongin 외 7명

Diabetes and Metabolism Journal

2022 .07